Abacavir and Lamivudine
Active substance: ABACAVIR SULFATE, LAMIVUDINE
TABLET, FILM COATED · ABACAVIR SULFATE 600 mg/1, LAMIVUDINE 300 mg/1
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- ABACAVIR SULFATE · 600 mg/1
- LAMIVUDINE · 300 mg/1
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 65 |
|
| EU 2 |
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-351d-7650-9c37-03f7e402b1ee,01a120c3-4121-75d4-9af7-203ac6065118,01a120c3-5f2e-788f-9683-790dc6670071,01a120c3-6071-7d0a-a6f5-6e7c688e2330,01a120c3-671b-7efc-b1f1-fc2142c3c3ab;count=37 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-657b-79f2-9cba-6d98326e4180,01a1208d-7a4e-76d7-8eb9-2f551561a6e8,01a1208d-7a58-752f-9ac8-6cf2004d8f1f,01a1208e-5043-74c4-821e-976217724acb,01a1208e-bbc1-78bd-8c7b-7d1fa7851760;count=15 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 65862-335
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 65862-335 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65862-335 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65862-335 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 65862-335 · Verified 2026-10-09 · open in source